Back to the trend of the day: Pakistan's cricket team turns pink today to push early breast cancer checks
Poly Rating · from the trend of the day

Breast Cancer Survival Rates by Country: 9 Nations

WHO estimates five-year breast cancer survival at 50–59% in Pakistan, while Australia’s older CONCORD-3 estimate was 89.5%.

  • No. 1: Pakistan
  • 9 places

01Final list

The leading AIs each built their own list of ten independently. Here is one result that is easy to check: every place has a reason, a source, and the list of AIs that included it.

Order: from most to least AI agreement.

A bright badge means this AI put the entry on its list. A dim badge means it did not.

  1. 1

    Pakistan

    WHO’s model puts five-year survival at 50–59%; a Lahore hospital cohort found 49.4% at stage III, but excluded stage IV and is not nationally representative.

    Included it: Claude, ChatGPT, Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen. Did not include: Kimi.

    In their lists: Claude: 1 · ChatGPT: 1 · Meta: 2 · Nemotron: 7 · Gemini: 9 · DeepSeek: 3 · Wenxin: 6 · Qwen: 1

    What each AI noted 8
    • Claudeplace 1

      Pakistan has the highest breast cancer mortality-to-incidence ratio of any Asian cricket nation I could compute (0.54): 18.6 deaths for every 34.2 new cases per 100,000 women.

    • ChatGPTplace 1

      WHO's model puts five-year survival in the 50–59% band; a 2020 Lahore hospital cohort found nearly half of its non-metastatic patients already at stage III.

      Source ↗
    • Metaplace 2

      1 in 9 lifetime risk, 70% stage III-IV, survival 50%, ASMR 18.6 highest in Asia, no organized screening

      Source ↗
    • Nemotronplace 7

      5-yr survival ~55% (hospital); 30% early-stage; MIR 0.53 — highest MIR in cricket world; <5% screening; 70% present locally advanced

    • Geminiplace 9

      Carries Asia's highest mortality-to-incidence gap, where an estimated 65%–70% of women present with late-stage tumors and 5-year survival averages ~50%–58%.

    • DeepSeekplace 3

      Sixty percent of Pakistani breast cancer patients present with locally advanced disease, and the mortality-to-incidence ratio is 0.61 — one of the highest in Asia.

    • Wenxinplace 6

      Below fifty percent survive five years — one of the largest early-detection gaps on any cricket-playing map

    • Qwenplace 1

      With the highest incidence rate in Asia, Pakistan sees half its patients survive past five years because early checks remain a privilege.

    8 AIs put it here
    Source ↗
  2. 2

    India

    CONCORD-3 reported 66.1% five-year net survival for 2010–2014; WHO’s newer model places India in the 60–69% band.

    Included it: Claude, ChatGPT, Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen. Did not include: Kimi.

    In their lists: Claude: 2 · ChatGPT: 3 · Meta: 5 · Nemotron: 6 · Gemini: 8 · DeepSeek: 4 · Wenxin: 5 · Qwen: 2

    What each AI noted 8
    • Claudeplace 2

      CONCORD-3 gives India the lowest breast cancer five-year survival it reports, 66.1%, against 89.5% in Australia and 90.2% in the US.

      Source ↗
    • ChatGPTplace 3

      The WHO 2017–21 model puts five-year survival at 60–69%, while a GLOBOCAN-based estimate records 98,337 breast-cancer deaths in 2022.

      Source ↗
    • Metaplace 5

      192,020 cases 98,337 deaths 2022 MIR 0.51 double Australia, 60% late, survival 66.1% lowest among high-volume cricket nations

    • Nemotronplace 6

      5-yr survival ~66% (hospital); 40% early-stage; MIR 0.31 — no national screening; 60%+ present at stage III–IV in rural areas

    • Geminiplace 8

      Loses the early detection advantage with a 5-year survival of 66.1% as more than 60% of women arrive at hospitals already in Stage III or IV.

    • DeepSeekplace 4

      India’s five-year net survival is 66.1%, and some hospital series report 62% of patients arriving with locally advanced breast cancer — a gap driven by screening uptake below 1%.

      Source ↗
    • Wenxinplace 5

      Sixty-six percent survive, but only about 30% of cases are caught early in a country of 1.4 billion

    • Qwenplace 2

      More than half of India's cases are caught at stage III or IV, dragging the national 5-year survival rate down to 66% despite rising incidence.

      Source ↗
    8 AIs put it here
    Source ↗
  3. 3

    Bangladesh

    WHO places survival in the 60–69% band, but the supplied sources provide no comparable national stage share or exact survival value.

    Included it: Claude, ChatGPT, Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen. Did not include: Kimi.

    In their lists: Claude: 3 · ChatGPT: 4 · Meta: 4 · Nemotron: 8 · Gemini: 10 · DeepSeek: 5 · Wenxin: 9 · Qwen: 3

    What each AI noted 8
    • Claudeplace 3

      Bangladesh has one of the lowest incidence rates here (15.2 per 100,000) but nearly half of those diagnosed die (MIR about 0.50).

    • ChatGPTplace 4

      WHO places five-year survival in the 60–69% band, but national stage and population-survival measurement remain sparse.

      Source ↗
    • Metaplace 4

      14,836 cases 2022, no population screening, ∼65% late stage, survival ∼55% estimated

      Source ↗
    • Nemotronplace 8

      5-yr survival ~58% (hospital); 35% early-stage; MIR 0.41 — no screening programme; cancer stigma delays presentation by 6–12 months

    • Geminiplace 10

      Faces acute shortages in diagnostic mammography, leaving more than 70% of female breast cancer cases diagnosed at locally advanced or metastatic stages.

    • DeepSeekplace 5

      Bangladesh has a mortality-to-incidence ratio of about 0.50 and a five-year survival estimate near 58% in a triple-negative cohort — early detection is rare and advanced disease common.

    • Wenxinplace 9

      Just over sixty percent survive five years; with one oncologist per 100,000 people, late-stage diagnosis is the norm

    • Qwenplace 3

      Lacking a national screening program, Bangladesh faces a massive detection gap where most women only seek help once the disease has advanced.

    8 AIs put it here
    Source ↗
  4. 4

    Australia

    CONCORD-3 reported 89.5% five-year net survival for 2010–2014; it is a high-survival comparator, though later national measures use different methods.

    Included it: Claude, ChatGPT, Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen. Did not include: Kimi.

    In their lists: Claude: 9 · ChatGPT: 10 · Meta: 10 · Nemotron: 1 · Gemini: 1 · DeepSeek: see list · Wenxin: 2 · Qwen: 9

    What each AI noted 8
    • Claudeplace 9

      Australia's five-year breast cancer survival is 89.5% (CONCORD-3) to 93% (AIHW), and half of eligible women still don't use the screening programme.

      Source ↗
    • ChatGPTplace 10

      Australia's 2010–14 CONCORD net survival was 89.5%, while its latest OECD screening series shows 51.3% coverage in 2023—high outcomes do not mean every eligible woman is screened.

    • Metaplace 10

      Survival 89.5% vs 40% South Africa, ASIR 101.47 ASMR 12.3, screening 51.7% but >60% early stage meets WHO target – smallest gap

    • Nemotronplace 1

      91.5% 5-yr survival; 72% early-stage (I–II); MIR 0.14 — best in cricket world; screening 54% but high symptom awareness drives early presentation

      Source ↗
    • Geminiplace 1

      Leads world cricket with a 5-year net survival of 89.5%–91.5% and over 75% of breast cancers diagnosed at early Stage I or II.

      Source ↗
    • DeepSeek

      Named differently in its own list: open the full list.

      see list
    • Wenxinplace 2

      Ninety-one percent survive five years, but the country still loses 3,000 women a year to a disease caught too late

    • Qwenplace 9

      A 90% five-year survival rate reflects decades of screening, yet rural and Indigenous communities still face delayed diagnoses that skew the national averages.

    8 AIs put it here
    Source ↗
  5. 5

    England

    CONCORD-3 and national screening data point to stronger outcomes than the widest-gap entries, but the figures refer to different periods and measures.

    Included it: Claude, Meta, Nemotron, Gemini, Kimi, DeepSeek, Wenxin, Qwen. Did not include: ChatGPT.

    In their lists: Claude: 8 · Meta: 9 · Nemotron: 2 · Gemini: 3 · Kimi: 8 · DeepSeek: 10 · Wenxin: 1 · Qwen: 8

    What each AI noted 8
    • Claudeplace 8

      In England, stage 1 breast cancer has almost 100% five-year survival and stage 2 about 90%; the gap is in who is caught that early, with 70.6% screening uptake.

      Source ↗
    • Metaplace 9

      ASIR 94.0 ASMR 14.0 2022, screening 71.8% coverage 2024/25 recovering post-COVID, survival ∼85.6%

    • Nemotronplace 2

      89.5% 5-yr survival; 70% early-stage; MIR 0.19 — NHS screening 65% catches most, but deprived areas lag 10–15 pts behind

      Source ↗
    • Geminiplace 3

      Records an 85.6% five-year net survival, catching over 70% of tumors early via the NHS population-based mammography scheme.

      Source ↗
    • Kimiplace 8

      Six in ten English breast cancers are stage I at diagnosis — the screening programme finds them before symptoms, which is exactly what the pink days in Lahore and Karachi are trying to build.

      Source ↗
    • DeepSeekplace 10

      England’s five-year survival is about 86%, but 8.4% of cases are still diagnosed at stage III and 4.8% at stage IV — a smaller but persistent late-diagnosis tail.

    • Wenxinplace 1

      Eighty-seven in a hundred women survive five years — the best net survival among test-playing nations and a gap of 24 points over Pakistan

    • Qwenplace 8

      England catches 85% of cases early, but a post-pandemic dip in screening coverage below 65% threatens to widen the gap for marginalized groups.

      Source ↗
    8 AIs put it here
    Source ↗
  6. 6

    Zimbabwe

    A Harare registry study reported 52% five-year relative survival; it is a city-registry result, not a national estimate, and differs from other cited study periods.

    Included it: Claude, Nemotron, Kimi, DeepSeek, Wenxin. Did not include: ChatGPT, Meta, Gemini, Qwen.

    In their lists: Claude: 4 · Nemotron: 10 · Kimi: 2 · DeepSeek: 2 · Wenxin: 10

    What each AI noted 5
    • Claudeplace 4

      Zimbabwe has no published survival figure, and the only evidence is regional: Eastern Africa's breast cancer MIR is 0.54, the same as Pakistan's.

      Source ↗
    • Nemotronplace 10

      5-yr survival ~45% (hospital); 25% early-stage; MIR 0.61 — worst in cricket world; no radiotherapy since 2020; screening <2%

    • Kimiplace 2

      In Harare's registry, fewer than half of women survived five years; in Bulawayo's, barely one in five saw three.

      Source ↗
    • DeepSeekplace 2

      Five-year relative survival for breast cancer in Zimbabwe has been reported as low as 37.9% in one registry analysis and 59% in a later SURVCAN analysis — still far below the 85% benchmark.

      Source ↗
    • Wenxinplace 10

      Not a Test nation, but included for the gap: below 40% survive five years, making the cricket pitch almost irrelevant to the outcome

    5 AIs put it here
    Source ↗
  7. 7

    Sri Lanka

    The national cancer institute hospital registry found 66% at stages I–II in 2016–2020; that registry sees about 40% of the country’s cancer patients.

    Included it: Claude, Meta, Nemotron, DeepSeek, Qwen. Did not include: ChatGPT, Gemini, Kimi, Wenxin.

    In their lists: Claude: 7 · Meta: 7 · Nemotron: 5 · DeepSeek: 8 · Qwen: 7

    What each AI noted 5
    • Claudeplace 7

      Two-thirds (66%) of Sri Lankan breast cancers in the National Cancer Institute registry were found at stage I–II, close to the WHO's 60% goal.

    • Metaplace 7

      3,955 cases 2022, survival ∼70% estimated, improving but 30-40% late still below WHO 60% early target

      Source ↗
    • Nemotronplace 5

      5-yr survival ~75% (hospital-based); 55% early-stage; MIR 0.22 — well-woman clinic network gives 30% screening but pathology delays upstage

    • DeepSeekplace 8

      Sri Lanka’s breast cancer-specific survival is about 78.8%, better than India or Pakistan, but advanced presentations remain common and the mortality-to-incidence ratio is 0.41.

      Source ↗
    • Qwenplace 7

      Sri Lanka boasts a 75% survival rate—higher than its neighbors—but still falls short of the WHO’s 60% early-stage diagnosis benchmark.

    5 AIs put it here
    Source ↗
  8. 8

    Nigeria

    WHO’s model estimates 27.7% five-year survival, but its sensitivity estimate rises to 47.7% without hospital-based registry inputs—a particularly wide uncertainty.

    Included it: ChatGPT, Nemotron, DeepSeek. Did not include: Claude, Meta, Gemini, Kimi, Wenxin, Qwen.

    In their lists: ChatGPT: 7 · Nemotron: see list · DeepSeek: see list

    What each AI noted 3
    • ChatGPTplace 7

      WHO's model estimates 27.7% five-year survival, but its sensitivity estimate jumps to 47.7% without hospital-based data—a particularly large uncertainty.

      Source ↗
    • Nemotron

      Named differently in its own list: open the full list.

      see list
    • DeepSeek

      Named differently in its own list: open the full list.

      see list
    3 AIs put it here
    Source ↗
  9. 9

    Afghanistan

    One AI cited 56% stage III–IV among Afghan patients registered in Pakistan; no comparable national survival figure was established in the supplied answers.

    Included it: Meta, DeepSeek. Did not include: Claude, ChatGPT, Nemotron, Gemini, Kimi, Wenxin, Qwen.

    In their lists: Meta: 3 · DeepSeek: 1

    What each AI noted 2
    • Metaplace 3

      No national registry, low HDI, estimated incidence 23.5, survival ∼45%, <20% early stage vs WHO 60% target

      Source ↗
    • DeepSeekplace 1

      Five-year survival is estimated at 40–49%, and 56% of Afghan breast cancer patients in a cross-border registry presented at stage III or IV — the widest early-detection gap in this ranking.

      Source ↗
    2 AIs put it here
    Source ↗

More about the top three ↓

02More about the top three

The ranking is above. Here is more about the three places at the top: what they are, why they are here, and what is worth knowing.

Pakistan’s estimate is for 2017–2021, India’s exact figure is for 2010–2014, and Bangladesh has only a band.

1Pakistan

No. 1 — Pakistan. On the lists of 8 of 9 AIs; median place there: 2.5. The AIs placed Pakistan first because they cited low survival, late diagnosis and high mortality relative to new cases.

Did you know

  • The Edhi Foundation’s ambulance service began in 1948. Guinness World Records lists it as the largest volunteer ambulance organisation. — (voice only)

    Source ↗
What it is
Pakistan’s breast cancer survival estimate is modelled by WHO.
Its edge
Its 50–59% band is below the 60–69% bands for India and Bangladesh.
Who should know
Useful to readers comparing country survival estimates and their limits.
  • Five-year breast cancer survival50–59%
Why it is here

  • WHO estimates Pakistan’s five-year breast cancer survival at 50–59% for 2017–2021, below India and Bangladesh, both in the 60–69% band. — (voice only)

    Source ↗

  • In one Lahore hospital cohort, 49.4% of patients had stage III cancer. The study excluded stage IV cases, so this is not a national figure. — (voice only)

    Source ↗
History

  • In 1947, Pakistan began amid a huge refugee crisis after Partition. Its first census, in 1951, recorded 7 million refugees—20 percent of the population at the time.

    Source ↗
Keep in mind

  • The WHO figure is modelled, combining registry data, country submissions and other factors. It is not a direct national registry measurement.

    Source ↗ ✓ confirmed by several AIs
What people say

  • “If I am alive today, it is because I talked about it openly and refused to be passive about it,” she told DW. — Gulnaz Ayaz

    Source ↗
Where to go further

  • Open the WHO’s country survival estimates and look up Pakistan first; check the estimate’s year and method alongside the survival band. — (voice only)

    Source ↗
Compare the top three ↓

2India

No. 2 — India. On the lists of 8 of 9 AIs; median place there: 4.5. The AIs placed India here because they cited 66.1% survival and frequent late diagnosis.

Did you know

  • India’s Mars Orbiter Mission reached Mars orbit on its first attempt, on 24 September 2014. It remained operational for more than eight years, though it was designed for six months. — (voice only)

    Source ↗
What it is
India’s survival is reported as an exact older figure and a newer WHO band.
Its edge
Its 66.1% figure is more exact than Bangladesh’s band.
Who should know
Useful to readers comparing survival reports across years and methods.
  • Five-year breast cancer survival66.1%
Why it is here

  • WHO’s newer estimate puts India in the 60–69% five-year survival band for 2017–2021, the same band as Bangladesh and above Pakistan’s 50–59%. — (voice only)

    Source ↗
History

  • In 1947, Britain’s rushed Partition created independent India and Pakistan. The border was announced two days after independence, leaving people uncertain about which country they would be in.

    Source ↗
Keep in mind

  • CONCORD-3’s 66.1% figure is for Karunagappally, not all of India, and covers women diagnosed in 2010–2014.

    Source ↗

  • The newer WHO estimate uses a model for 2017–2021, combining observed registry estimates with other data and regional trends; it is not a national registry count.

    Source ↗
What people say

  • “I thought life is infinite, which it isn’t” — Vogue India interviewee

    Source ↗
Where to go further

  • Download India’s ICMR annual report and look for the breast cancer survival study across 11 population-based registries; compare its regional and stage findings. — (voice only)

    Source ↗
Compare the top three ↓

3Bangladesh

No. 3 — Bangladesh. On the lists of 8 of 9 AIs; median place there: 4.5. The AIs placed Bangladesh here because they cited low screening and late diagnosis, while exact national survival data was unavailable.

Did you know

  • The Bangladesh part of the Sundarbans is the world’s largest contiguous mangrove forest. UNESCO’s site description lists 260 bird species there, as well as Bengal tigers and estuarine crocodiles. — (voice only)

    Source ↗
What it is
Bangladesh’s WHO survival estimate is given as a band.
Its edge
No edge over the other two is established by the supplied survival data.
Who should know
Useful to readers comparing country estimates while noting evidence gaps.
  • Five-year breast cancer survival60–69%
Why it is here

  • WHO places Bangladesh in the 60–69% five-year survival band for 2017–2021, the same band as India and above Pakistan’s 50–59%. — (voice only)

    Source ↗

  • Across South-East Asia, WHO estimates median five-year survival at 66.3%; Bangladesh is among the five of 10 countries in the region in the 60–69% band. — (voice only)

    Source ↗
History

  • In 1970, Cyclone Bhola devastated East Pakistan. The disaster and the government’s weak relief response deepened anger; after a nine-month war, Pakistan surrendered in December 1971 and Bangladesh became independent.

    Source ↗
Keep in mind

  • The WHO survival estimate is modelled from registry observations, country submissions and other information; the supplied sources give a band, not an exact national survival value.

    Source ↗
What people say

  • “One day, I felt a different kind of pain on my breast.” — Dr. Akhtarunnessa Chowdhury

    Source ↗
Where to go further

  • Explore Bangladesh’s official cervical and breast cancer statistics dashboard; start with the screening charts, which show what the collected data covers. — (voice only)

    Source ↗
Compare the top three ↓

The top three side by side

PakistanIndiaBangladesh
In the AIs' lists8 / 98 / 98 / 9
Five-year breast cancer survival50–59%66.1%60–69%
Put first byClaude, ChatGPT, Qwen——

Places with the same number of AIs are ordered by their average place in the AIs' own lists.

More ratings

03Worth knowing

What the AIs noticed while building the list.

WHO estimates global median five-year survival at 77.8% for 2017–2021, with 87.3% in high-income countries and 41.9% in low-income countries.

Noticed by:
Included it: Claude, ChatGPT, Gemini. Did not include: Meta, Nemotron, Kimi, DeepSeek, Wenxin, Qwen.
Source ↗

Pakistan’s Lahore stage study and WHO survival estimate describe different things: a single tertiary-centre stage cohort cannot be read as a national survival or stage rate.

Noticed by:
Included it: Claude, ChatGPT, Kimi. Did not include: Meta, Nemotron, Gemini, DeepSeek, Wenxin, Qwen.
Source ↗

Nigeria’s WHO estimate moves from 27.7% to 47.7% when hospital-based registry inputs are excluded, showing how sensitive country rankings can be to data coverage.

Noticed by:
Included it: ChatGPT, Nemotron, DeepSeek. Did not include: Claude, Meta, Gemini, Kimi, Wenxin, Qwen.
Source ↗

Mortality-to-incidence ratios are calculated from deaths and cases; they are a rough cross-check, not a substitute for five-year survival.

Noticed by:
Included it: Claude, ChatGPT, Nemotron. Did not include: Meta, Gemini, Kimi, DeepSeek, Wenxin, Qwen.
Source ↗

04Questions people ask

What is the breast cancer survival rate?

There is no single worldwide rate. WHO estimates median five-year net survival at 77.8% for 2017–2021, ranging from 41.9% in low-income countries to 87.3% in high-income countries.

What is the breast cancer survival rate in Pakistan?

WHO’s model places Pakistan at 50–59% five-year net survival for 2017–2021. The estimate is modelled and should not be confused with results from a single Lahore hospital cohort.

Source ↗
Why do sources give different survival rates?

They may cover different diagnosis years, populations and measures. For South Africa, WHO reports 54.4% for 2017–2021 and 64.5% in a sensitivity analysis excluding hospital-based registry inputs.

Source ↗

05How we counted

In plain words, no formulas.

1The question

Top 10 Cricket Nations by the Breast Cancer Early-Detection Gap

2Why this topic

It places survival and stage at diagnosis side by side for the countries in today's series and their cricket rivals, which no single survival or incidence table does.

3Where it applies

Test-playing and leading one-day cricket nations with published survival or stage data

4What we looked at

  • Five-year age-standardised net survival for women with breast cancer
  • Share of cases diagnosed at an advanced stage (III–IV) compared with an early stage (I–II), from national registries or published studies
  • Mortality-to-incidence ratio as a cross-check where survival data are missing
  • WHO global breast cancer survival estimates — Predicted age-standardised five-year net survival for 2017–2021, using registry observations, country submissions and modelling; some results are bands.
  • CONCORD-3 — Five-year age-standardised net survival from population-based registries for women diagnosed 2010–2014; coverage varies by country.
  • National registries and published stage studies — Stage at diagnosis; hospital cohorts may not represent a whole country and staging methods differ.
  • IARC GLOBOCAN 2022 — Age-standardised breast cancer incidence and mortality per 100,000; mortality-to-incidence ratios calculated from these rates are only a rough cross-check, not survival estimates.

5Who ranked

The leading AIs, each building its own list of ten independently and naming a source for every place: Claude, ChatGPT, Meta, Nemotron, Gemini, Kimi, DeepSeek, Wenxin, Qwen.

6How the places were set

The same entry written differently by different AIs was counted as one. The more AIs put an entry on their list, and the higher they put it, the higher its place. "AI agreement" shows how many of the AIs had it on their own list. Sources are only those the AIs found themselves; nothing was added by hand.

06Each AI's own list

🇺🇸 Claude10 places · 2 notes

The same question, answered by Claude alone. The final list above combines all the AIs.

  1. 1
    Pakistan

    Pakistan has the highest breast cancer mortality-to-incidence ratio of any Asian cricket nation I could compute (0.54): 18.6 deaths for every 34.2 new cases per 100,000 women.

  2. 2
    India

    CONCORD-3 gives India the lowest breast cancer five-year survival it reports, 66.1%, against 89.5% in Australia and 90.2% in the US.

    Source ↗
  3. 3
    Bangladesh

    Bangladesh has one of the lowest incidence rates here (15.2 per 100,000) but nearly half of those diagnosed die (MIR about 0.50).

  4. 4
    Zimbabwe

    Zimbabwe has no published survival figure, and the only evidence is regional: Eastern Africa's breast cancer MIR is 0.54, the same as Pakistan's.

    Source ↗
  5. 5
    South Africa

    59% of women in a five-hospital South African cohort arrived at stage III–IV, and no national survival figure exists in the sources I found.

  6. 6
    West Indies (Caribbean)

    The Caribbean's breast cancer MIR of 0.40 sits halfway between Australia–New Zealand (0.16) and Eastern Africa (0.54).

    Source ↗
  7. 7
    Sri Lanka

    Two-thirds (66%) of Sri Lankan breast cancers in the National Cancer Institute registry were found at stage I–II, close to the WHO's 60% goal.

  8. 8
    England

    In England, stage 1 breast cancer has almost 100% five-year survival and stage 2 about 90%; the gap is in who is caught that early, with 70.6% screening uptake.

    Source ↗
  9. 9
    Australia

    Australia's five-year breast cancer survival is 89.5% (CONCORD-3) to 93% (AIHW), and half of eligible women still don't use the screening programme.

    Source ↗
  10. 10
    New Zealand

    New Zealand shares Australia's regional breast cancer MIR of 0.16, the lowest I found, but I found no New Zealand-specific survival or stage numbers.

    Source ↗

What Claude noticed

The mortality-to-incidence ratio ranges from about 0.16 (Australia–New Zealand) to about 0.54 (Eastern Africa; Pakistan by my calculation): in the high-incidence countries a small share of women die, in the low-incidence ones about half.

Source ↗

Africa as a whole has the highest breast cancer mortality-to-incidence ratio in the world, 0.510.

Source ↗
🇺🇸 ChatGPT10 places · 3 notes

The same question, answered by ChatGPT alone. The final list above combines all the AIs.

  1. 1
    Pakistan breast cancer early-detection gap

    WHO's model puts five-year survival in the 50–59% band; a 2020 Lahore hospital cohort found nearly half of its non-metastatic patients already at stage III.

    Source ↗
  2. 2
    South Africa breast cancer early-detection gap

    A WHO estimate of 54.4% five-year survival is far below high-income-country levels, but rises to 64.5% when hospital-based registry inputs are excluded.

    Source ↗
  3. 3
    India breast cancer early-detection gap

    The WHO 2017–21 model puts five-year survival at 60–69%, while a GLOBOCAN-based estimate records 98,337 breast-cancer deaths in 2022.

    Source ↗
  4. 4
    Bangladesh breast cancer early-detection gap

    WHO places five-year survival in the 60–69% band, but national stage and population-survival measurement remain sparse.

    Source ↗
  5. 5
    Zimbabwe breast cancer early-detection gap

    A registry study found five-year relative survival ranging from 52% in Harare to 43% in a Kenyan registry, underscoring how sharply outcomes vary by place and data source.

    Source ↗
  6. 6
    Kenya breast cancer early-detection gap

    The same regional registry research reports 70% five-year relative survival in Nairobi but 43% in Eldoret—a warning against treating one city as the country.

    Source ↗
  7. 7
    Nigeria breast cancer early-detection gap

    WHO's model estimates 27.7% five-year survival, but its sensitivity estimate jumps to 47.7% without hospital-based data—a particularly large uncertainty.

    Source ↗
  8. 8
    Bangladesh and India comparator: South Asian cricket nations

    Both countries sit in WHO's 60–69% survival band; country ordering within that band is not supported by the published banded result.

    Source ↗
  9. 9
    Sri Lanka breast cancer early-detection gap

    Sri Lanka reaches WHO's 70–79% survival band, above India and Bangladesh's band, although this does not establish a direct screening effect.

    Source ↗
  10. 10
    Australia breast cancer early-detection gap

    Australia's 2010–14 CONCORD net survival was 89.5%, while its latest OECD screening series shows 51.3% coverage in 2023—high outcomes do not mean every eligible woman is screened.

What ChatGPT noticed

Stage and survival rankings are not interchangeable: Pakistan's cited tertiary cohort had 49.4% stage III among non-metastatic patients, while WHO's country survival estimate is modelled across the population and period.

Source ↗

Nigeria illustrates why uncertainty belongs in the ranking: the WHO estimate changes from 27.7% to 47.7% when hospital-based registry estimates are excluded.

Source ↗

Mortality-to-incidence ratio is a rough cross-check, not a survival substitute: it divides all-age death counts by case counts and can differ from age-standardised survival measures.

Source ↗
🇺🇸 Meta10 places · 3 notes

The same question, answered by Meta alone. The final list above combines all the AIs.

  1. 1
    South Africa

    Survival 40% vs 90.2% USA – 50-point gap, ASIR 47.8 ASMR 16.0, Pink ODI since 2013 funds Charlotte Maxeke unit

  2. 2
    Pakistan

    1 in 9 lifetime risk, 70% stage III-IV, survival 50%, ASMR 18.6 highest in Asia, no organized screening

    Source ↗
  3. 3
    Afghanistan

    No national registry, low HDI, estimated incidence 23.5, survival ∼45%, <20% early stage vs WHO 60% target

    Source ↗
  4. 4
    Bangladesh

    14,836 cases 2022, no population screening, ∼65% late stage, survival ∼55% estimated

    Source ↗
  5. 5
    India

    192,020 cases 98,337 deaths 2022 MIR 0.51 double Australia, 60% late, survival 66.1% lowest among high-volume cricket nations

  6. 6
    Zimbabwe

    Africa MIR 0.46 highest globally, ASIR 40.5 Africa average, <20% screening coverage in low-income African countries

    Source ↗
  7. 7
    Sri Lanka

    3,955 cases 2022, survival ∼70% estimated, improving but 30-40% late still below WHO 60% early target

    Source ↗
  8. 8
    West Indies (Jamaica representative)

    Caribbean mortality ∼14-15 per 100k, 40% of countries fail WHO 60% early-stage target including Caribbean nations

    Source ↗
  9. 9
    England (United Kingdom)

    ASIR 94.0 ASMR 14.0 2022, screening 71.8% coverage 2024/25 recovering post-COVID, survival ∼85.6%

  10. 10
    Australia

    Survival 89.5% vs 40% South Africa, ASIR 101.47 ASMR 12.3, screening 51.7% but >60% early stage meets WHO target – smallest gap

What Meta noticed

Pakistan paradox – lower incidence 34.2 per 100k but ASMR 18.6 highest in Asia because 70% diagnosed stage III-IV and no organized screening programme

Source ↗

India 192,020 new cases and 98,337 deaths in 2022 gives MIR 0.51 – more than four times Australia MIR 0.12 – driven by 60% late-stage diagnosis vs 20% in USA

Source ↗

WHO Global Breast Cancer Initiative target is 60% of invasive cancers found at stage I-II – IARC study shows 40% of countries do not meet it, including 5 of 10 cricket nations in this ranking

Source ↗
🇺🇸 Nemotron10 places

The same question, answered by Nemotron alone. The final list above combines all the AIs.

  1. 1
    Australia breast cancer early-detection gap (2026 assessment)

    91.5% 5-yr survival; 72% early-stage (I–II); MIR 0.14 — best in cricket world; screening 54% but high symptom awareness drives early presentation

    Source ↗
  2. 2
    England breast cancer early-detection gap (2026 assessment)

    89.5% 5-yr survival; 70% early-stage; MIR 0.19 — NHS screening 65% catches most, but deprived areas lag 10–15 pts behind

    Source ↗
  3. 3
    New Zealand breast cancer early-detection gap (2026 assessment)

    88.8% 5-yr survival; 68% early-stage; MIR 0.18 — world-leading screening 72% but Māori women 20% less likely early diagnosis

    Source ↗
  4. 4
    South Africa breast cancer early-detection gap (2026 assessment)

    5-yr survival ~65% (public sector); 45% early-stage; MIR 0.35 — two-tier system: private 85% survival vs public 55%

  5. 5
    Sri Lanka breast cancer early-detection gap (2026 assessment)

    5-yr survival ~75% (hospital-based); 55% early-stage; MIR 0.22 — well-woman clinic network gives 30% screening but pathology delays upstage

  6. 6
    India breast cancer early-detection gap (2026 assessment)

    5-yr survival ~66% (hospital); 40% early-stage; MIR 0.31 — no national screening; 60%+ present at stage III–IV in rural areas

  7. 7
    Pakistan breast cancer early-detection gap (2026 assessment)

    5-yr survival ~55% (hospital); 30% early-stage; MIR 0.53 — highest MIR in cricket world; <5% screening; 70% present locally advanced

  8. 8
    Bangladesh breast cancer early-detection gap (2026 assessment)

    5-yr survival ~58% (hospital); 35% early-stage; MIR 0.41 — no screening programme; cancer stigma delays presentation by 6–12 months

  9. 9
    West Indies (Caribbean) breast cancer early-detection gap (2026 assessment)

    Regional 5-yr survival ~65–70%; 50% early-stage; MIR 0.28 — Jamaica 72% survival but Haiti 40%; screening 10–25% fragmented

  10. 10
    Zimbabwe breast cancer early-detection gap (2026 assessment)

    5-yr survival ~45% (hospital); 25% early-stage; MIR 0.61 — worst in cricket world; no radiotherapy since 2020; screening <2%

🇺🇸 Gemini10 places

The same question, answered by Gemini alone. The final list above combines all the AIs.

  1. 1
    Australia

    Leads world cricket with a 5-year net survival of 89.5%–91.5% and over 75% of breast cancers diagnosed at early Stage I or II.

    Source ↗
  2. 2
    New Zealand

    Achieves an 87.6% five-year survival rate backed by a nationwide BreastScreen Aotearoa early-detection framework.

  3. 3
    England (United Kingdom)

    Records an 85.6% five-year net survival, catching over 70% of tumors early via the NHS population-based mammography scheme.

    Source ↗
  4. 4
    Ireland

    Features an 86.0% five-year survival supported by the nationwide BreastCheck screening service.

  5. 5
    South Africa

    Bears a sharp two-tier diagnostic divide, where private-sector survival approaches 80% while public tertiary centers see over 65% of cases at Stage III or IV.

  6. 6
    West Indies (Caribbean Cricket Nations)

    Shows five-year survival near 62%–68% across regional registries, challenged by high triple-negative rates and fragmented inter-island pathology networks.

  7. 7
    Sri Lanka

    Leverages free universal primary health centers to detect ~50% of cases early, yielding a five-year survival around 65%–70%.

  8. 8
    India

    Loses the early detection advantage with a 5-year survival of 66.1% as more than 60% of women arrive at hospitals already in Stage III or IV.

  9. 9
    Pakistan

    Carries Asia's highest mortality-to-incidence gap, where an estimated 65%–70% of women present with late-stage tumors and 5-year survival averages ~50%–58%.

  10. 10
    Bangladesh

    Faces acute shortages in diagnostic mammography, leaving more than 70% of female breast cancer cases diagnosed at locally advanced or metastatic stages.

🇨🇳 Kimi10 places · 3 notes

The same question, answered by Kimi alone. The final list above combines all the AIs.

  1. 1
    Pakistan — widest early-detection gap

    Over 70% of Pakistani women are diagnosed at stage III or IV — the worst stage profile in world cricket, in the country playing pink today.

    Source ↗
  2. 2
    Zimbabwe — widest measured survival gap

    In Harare's registry, fewer than half of women survived five years; in Bulawayo's, barely one in five saw three.

    Source ↗
  3. 3
    South Africa — a two-tier gap inside one country

    A woman with breast insurance survives like an Australian; without it, like a Zimbabwean — 86% versus 53.5%.

    Source ↗
  4. 4
    Bangladesh — the data-poor, high-ratio gap

    No national survival series exists at all — but GLOBOCAN's modelled ratio implies half of all diagnosed women still die of the disease.

    Source ↗
  5. 5
    India — measured at two-thirds survival

    The best-measured big gap: 57–60% of Indian women arrive at stage III/IV, and national survival is 66% — against 90% in the countries India plays this week.

    Source ↗
  6. 6
    West Indies — the invisible gap

    The only Test nation where no one can say the survival rate: Jamaica has no published national survival or stage-at-diagnosis series to rank at all.

    Source ↗
  7. 7
    Sri Lanka — a third arrive late, and it is improving

    Sri Lanka detects two-thirds of breast cancers early — already close to the WHO's 60% goal, yet 37% still arrive at stage III or beyond.

  8. 8
    England — early detection as the system default

    Six in ten English breast cancers are stage I at diagnosis — the screening programme finds them before symptoms, which is exactly what the pink days in Lahore and Karachi are trying to build.

    Source ↗
  9. 9
    Australia — smallest measured gap among the subcontinent's rivals

    89.5% five-year survival and the world's most successful pink fundraiser — Australia's gap is no longer detection but participation and equity.

    Source ↗
  10. 10
    New Zealand — the smallest overall gap, with one sharp edge

    Nine in ten New Zealand women survive five years — but for Pacific women it is 84%, and a third of eligible women still skip the free mammogram.

What Kimi noticed

The single most striking number in world oncology is this gap: 90.2% five-year breast cancer survival in the USA and 89.5% in Australia, against 66.1% in India — and under 50% in Pakistan, where the team is wearing pink today.

Source ↗

Stage at diagnosis explains almost everything: across 14 sub-Saharan African registries, women diagnosed early had 78% three-year survival versus 40.3% for late-stage disease — same disease, different arrival time.

Source ↗

South Africa carries two countries in one: insured women survive at 84–86% (US/UK level) while the public-hospital cohort survives at 53.5% — the widest internal two-tier gap in world cricket.

Source ↗
🇨🇳 DeepSeek10 places · 2 notes

The same question, answered by DeepSeek alone. The final list above combines all the AIs.

  1. 1
    Afghanistan

    Five-year survival is estimated at 40–49%, and 56% of Afghan breast cancer patients in a cross-border registry presented at stage III or IV — the widest early-detection gap in this ranking.

    Source ↗
  2. 2
    Zimbabwe

    Five-year relative survival for breast cancer in Zimbabwe has been reported as low as 37.9% in one registry analysis and 59% in a later SURVCAN analysis — still far below the 85% benchmark.

    Source ↗
  3. 3
    Pakistan

    Sixty percent of Pakistani breast cancer patients present with locally advanced disease, and the mortality-to-incidence ratio is 0.61 — one of the highest in Asia.

  4. 4
    India

    India’s five-year net survival is 66.1%, and some hospital series report 62% of patients arriving with locally advanced breast cancer — a gap driven by screening uptake below 1%.

    Source ↗
  5. 5
    Bangladesh

    Bangladesh has a mortality-to-incidence ratio of about 0.50 and a five-year survival estimate near 58% in a triple-negative cohort — early detection is rare and advanced disease common.

  6. 6
    South Africa

    South Africa’s breast cancer survival has been estimated at about 53% in older CONCORD analyses, and two-thirds of registry cases have unknown stage — a data gap that itself signals weak early-detection tracking.

  7. 7
    West Indies (Jamaica)

    Jamaica’s breast cancer mortality has been reported at 66 per 100,000 in 2026, and one hospital series found 62% of patients diagnosed at stage IV — a late-presentation crisis.

  8. 8
    Sri Lanka

    Sri Lanka’s breast cancer-specific survival is about 78.8%, better than India or Pakistan, but advanced presentations remain common and the mortality-to-incidence ratio is 0.41.

    Source ↗
  9. 9
    New Zealand

    New Zealand’s five-year survival is around 89%, and 69.8% of eligible women were screened in 2024 — a small early-detection gap, though Māori and Pacific women remain below the target.

    Source ↗
  10. 10
    England

    England’s five-year survival is about 86%, but 8.4% of cases are still diagnosed at stage III and 4.8% at stage IV — a smaller but persistent late-diagnosis tail.

What DeepSeek noticed

The gap between the best and worst cricket nations is roughly 50 percentage points of five-year survival: about 89.5% in Australia versus 40–49% in Afghanistan.

Source ↗

South Africa’s stage data are two-thirds ‘unknown’, which means its 21% advanced-stage share is calculated on a minority of cases — a data-quality gap that makes international ranking inherently uncertain.

Source ↗
🇨🇳 Wenxin10 places

The same question, answered by Wenxin alone. The final list above combines all the AIs.

  1. 1
    England breast cancer survival (CONCORD-3, 2014–2018)

    Eighty-seven in a hundred women survive five years — the best net survival among test-playing nations and a gap of 24 points over Pakistan

  2. 2
    Australia breast cancer survival (CONCORD-3, 2014–2018)

    Ninety-one percent survive five years, but the country still loses 3,000 women a year to a disease caught too late

  3. 3
    New Zealand breast cancer survival (CONCORD-3, 2014–2018)

    Eighty-four percent survive, but Māori women face a 15-point gap — a country's worst internal disparity

  4. 4
    South Africa breast cancer survival (CONCORD-3, 2014–2018)

    Sixty-two percent survive five years — the lowest among test-playing nations, and black women fare even worse

  5. 5
    India breast cancer survival (CONCORD-3 / registry data, 2014–2018)

    Sixty-six percent survive, but only about 30% of cases are caught early in a country of 1.4 billion

  6. 6
    Pakistan breast cancer survival (registry/estimates, 2014–2018)

    Below fifty percent survive five years — one of the largest early-detection gaps on any cricket-playing map

  7. 7
    West Indies (Caribbean region) breast cancer survival (regional estimates)

    The region averages around 70% survival, but Haiti and Jamaica drag the number down and no single national figure exists for the team

  8. 8
    Sri Lanka breast cancer survival (registry data)

    Sixty-two percent survive, but the civil-war legacy means data is thin and the true gap may be larger

  9. 9
    Bangladesh breast cancer survival (registry estimates)

    Just over sixty percent survive five years; with one oncologist per 100,000 people, late-stage diagnosis is the norm

  10. 10
    Zimbabwe breast cancer survival (regional, limited data)

    Not a Test nation, but included for the gap: below 40% survive five years, making the cricket pitch almost irrelevant to the outcome

🇨🇳 Qwen10 places

The same question, answered by Qwen alone. The final list above combines all the AIs.

  1. 1
    Pakistan

    With the highest incidence rate in Asia, Pakistan sees half its patients survive past five years because early checks remain a privilege.

  2. 2
    India

    More than half of India's cases are caught at stage III or IV, dragging the national 5-year survival rate down to 66% despite rising incidence.

    Source ↗
  3. 3
    Bangladesh

    Lacking a national screening program, Bangladesh faces a massive detection gap where most women only seek help once the disease has advanced.

  4. 4
    West Indies

    Across the Caribbean islands, a higher prevalence of aggressive triple-negative breast cancer meets delayed diagnoses, widening the survival gap.

    Source ↗
  5. 5
    South Africa

    Despite world-class private care, the public health system sees most women diagnosed at stage III or later, keeping the mortality-to-incidence ratio dangerously high.

    Source ↗
  6. 6
    Zimbabwe

    With limited national registry data, hospital studies show Zimbabwean women frequently present with stage IV disease, highlighting a severe early-detection void.

  7. 7
    Sri Lanka

    Sri Lanka boasts a 75% survival rate—higher than its neighbors—but still falls short of the WHO’s 60% early-stage diagnosis benchmark.

  8. 8
    England (UK)

    England catches 85% of cases early, but a post-pandemic dip in screening coverage below 65% threatens to widen the gap for marginalized groups.

    Source ↗
  9. 9
    Australia

    A 90% five-year survival rate reflects decades of screening, yet rural and Indigenous communities still face delayed diagnoses that skew the national averages.

  10. 10
    New Zealand

    New Zealand’s survival rates rival Australia’s, driven by a free screening program that catches the vast majority of cases before they spread.